The effects of native isolates of Pseudomonas fluorescens, Azospirillum brasilense, and Trichoderma harzianum on rooting and acclimatization of in vitro-grown shoots and plantlets of tea were evaluated. In vitro bacterization of P. fluorescens failed to establish, while both T. harzianum and A. brasilense retarded shoot growth, eventually overtaking shoot cultures in in vitro rooting. Acclimatization of rooted plantlets in soil amended with bioinoculants, either individually or in various combinations, promoted plantlet survival. Moreover, efficiency of nutrient uptake of plantlets was higher in the presence of microorganisms. Root rot or wilting of tissue culturederived plants was not observed in bioinoculant-treated plants, as they possessed relatively higher activities of defense enzymes, including peroxidase and phenylalanine ammonia lyase.

No abstract

The effect of two chemical elicitors (acibenzolar-S-methyl benzo-[1,2,3]-thiadiazole-7-carboxylic acid S-methyl ester [Boost 500SC]) and salicylic acid in inducing resistance in tea plants against blister blight disease caused by Exobasidium vexans Massee, was studied. Treatments with elicitors resulted in reduced severity of blister blight disease in nursery plants on challenge with the pathogen. There was a significant increase in the activities of defense enzymes like phenylalanine ammonia lyase, peroxidase and β-1,3-glucanase on elicitor treatments in tea leaves challenged with the pathogen than on unchallenged leaves. Acibenzolar-S-methyl (ASM) at 0.14% registered the lowest disease severity (25.2%), whereas treatments with salicylic acid were inferior. Under field conditions, the application of ASM at 0.14% resulted in disease protection of 25%. When ASM was applied in alternate rounds with a standard fungicide, the disease protection improved to 46.8%. The importance of incorporating ASM as a component in integrated disease management and also its importance in organic tea cultivation is discussed.

Background: Dyslipidemia is one of the most prevalent risk factors contributing to atherosclerotic cardiovascular disease. Clinical trials have demonstrated that treatment of dyslipidemia reduces cardiovascular events. Fenugreek seed powder supplementation has lipid-lowering activity, but has not been studied extensively. In light of this, we undertook the present study at tertiary care hospital in Amravati, Maharashtra, with the aim of studying the effect of fenugreek seed powder on serum lipid profile in patients with dyslipidemia & to determine the adverse effects of it. Methods: The study was a single blind placebo controlled study conducted on 60 patients with dyslipidemia from June 2022 to November 2022, after meeting inclusion and exclusion criteria. Results: It was found significant decrease in serum total cholesterol (237.32 to 204.51mg/dl) p value <0.001, serum LDL cholesterol (154.69 to 133.88 mg/dl) p value < 0.001 & serum triglycerides (196.95 to 165.09 mg/dl) p <0.01 with no effect on serum HDL cholesterol (41.11 to 38.92mg/dl) p >0.05, without any major side effects. Conclusion: Fenugreek seed powder significantly lowers serum total cholesterol, LDL cholesterol and triglyceride levels in dyslipidemia patients, with no effect on serum HDL cholesterol levels. fenugreek seed powder supplementation considerably improves lipid Profile. Hence it could be well-thought-out as an effective lipid lowering nutritional supplement. Further high quality & large scale studies are needed to decisively establish the clinical efficacy of fenugreek seed powder. Keywords: fenugreek seed powder; dyslipidemia; lipid profile; cholesterol; LDL; triglycerides; HDL